PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Low number of taste buds linked to older age, higher fasting blood sugar

2014-06-23
(Press-News.org) CHICAGO, IL—A study finds that the number of taste buds we have on our tongue decreases as we get older, and that the lower the number of taste buds, the more likely for fasting blood glucose (sugar) levels to be higher than normal. The results were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.

Because high fasting blood sugar level is a main characteristic of diabetes, the study findings suggest that the number of taste buds plays a role in glucose metabolism—how the body uses sugar—during aging, the authors proposed.

"The reduced number of taste buds with advancing age might be linked to the increased incidence of Type 2 diabetes among older adults," said the study's lead investigator, Chee Chia, MD, a medical officer at the National Institute of Aging (NIA) in Baltimore.

Diabetes affects more than 25 percent of Americans over age 65, according to the National Institute of Diabetes and Digestive and Kidney Diseases.

Chia explained why she and a co-worker at the NIA, Josephine Egan, MD, thought there might be a connection between taste buds and diabetes. Taste buds at the tip of the tongue, whose medical term is "fungiform papillae," contain sweet taste receptors, and past studies show that people with Type 2 diabetes have impaired sweet taste. Furthermore, animal studies suggest that taste buds produce hormones that are important for glucose metabolism and that, in rodents, taste buds decrease in number with age.

To learn whether humans also have an age-related decline in the density of taste buds, Chia and Egan analyzed data from 353 adults who participated in the NIA's Baltimore Longitudinal Study of Aging between 2011 and 2014. This ongoing observational study of normal aging in community-dwelling volunteers included counts of the density, or number, of taste buds at the tip of the tongue after staining the subject's tongue with blue food dye.

The researchers found that older age was associated with fewer taste buds, a finding also seen in a larger clinical study published last October (Beaver Dam Offspring Study).

In addition, Chia reported that the fewer taste buds that subjects had, the higher their fasting blood sugar levels were and the less they had of a beneficial fat cell hormone called adiponectin. Prior studies found that obesity and Type 2 diabetes are associated with lower adiponectin levels.

"To my knowledge, this is the first association found between the number of taste buds and fasting glucose," Chia said. "It's very possible they could be unrelated, so we plan to do the study over a longer time, to confirm our findings."

"It's also possible," she added, "that having fewer taste buds means fewer hormones are secreted that may control glucose metabolism."

INFORMATION: Founded in 1916, the Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, the Endocrine Society's membership consists of over 17,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Washington, DC. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at https://twitter.com/#!/EndoMedia.


ELSE PRESS RELEASES FROM THIS DATE:

Growth hormone defect may protect against diabetes, cancer in unique ecuador population

2014-06-23
CHICAGO, IL — People who lack growth hormone (GH) receptors also appear to have marked insulin sensitivity that prevents them from developing diabetes and lowers their risk for cancer, despite their increased percentage of body fat, new research finds. The results were presented Sunday, June 22, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago. "We have shown that people who, due to a genetic defect, are unable to respond to growth hormone have an increased sensitivity to insulin that safeguards them ...

Hypothyroidism may lead to impaired driving

2014-06-23
CHICAGO, IL — People with significant hypothyroidism can experience impaired driving similar to those who are driving when intoxicated by alcohol, a new study finds. The results were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago. Hypothyroidism, insufficient thyroid hormone, is very common and has been known to cause impairment of many bodily functions, including brain function. Until now, studies have not sufficiently explored the extent of brain impairment and whether hypothyroid ...

High blood sugar causes brain changes that raise depression risk

2014-06-23
CHICAGO, IL — Researchers have found a possible biological reason why people with diabetes are prone to depression. A new study shows that high blood glucose (sugar) levels in patients with Type 1 diabetes increase the levels of a brain neurotransmitter associated with depression, and alter the connections between regions of the brain that control emotions. The results will be presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago. "It was traditionally thought that patients with Type 1 or ...

Soy supplements appear to be safe, beneficial in diabetic men

2014-06-23
CHICAGO, IL—Soy protein supplements, which contain natural estrogens, do not reduce testosterone levels in men with Type 2 diabetes who already have borderline-low testosterone, according to a new study. The results were presented Saturday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago. "Because soy contains phytoestrogens that are similar to the female hormone estrogen, it was not known whether consumption of soy could reduce testosterone levels in men with Type 2 diabetes, who are at increased risk ...

Most people with type 1 diabetes do not use diabetes devices to get long-term data

2014-06-23
CHICAGO, IL—Almost 70 percent of adults with Type 1 diabetes never use their blood glucose self-monitoring devices or insulin pumps to download historical data about their blood sugar levels and insulin doses—information that likely would help them manage their disease better. These new survey results, which were presented Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago, also show that only 12 percent of patients regularly review their past glucose and insulin pump data at home. "This research ...

BPA exposure during fetal development raises risk of precancerous prostate lesions

2014-06-23
CHICAGO, IL — A new study has found for the first time that the endocrine-disrupting chemical bisphenol A (BPA) reprograms the developing prostate, making the gland more susceptible to precancerous lesions and other diseases later in a man's life. The results will be reported Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago. "By using two novel models of human prostate development involving embryonic stem cells, this study is the first to show that low doses of BPA can actually reprogram human ...

Denosumab treatment for postmenopausal osteoporosis increases bone density

2014-06-23
CHICAGO, IL — Postmenopausal women with osteoporosis who take denosumab long-term have increased bone density, sustained low rate of fractures, and a favorable benefit/risk profile, a new multinational study finds. The results were presented Sunday, June 22, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago. "This study provides reassurance to physicians and their patients that long-term treatment with denosumab for at least 8 years leads to significant increases in bone density and is safe for appropriately ...

Empagliflozin lowers high blood pressure and blood sugar in diabetics

2014-06-23
CHICAGO, IL — An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago. This improvement in blood pressure reportedly was accompanied by a reduction in blood glucose (sugar) levels after 12 weeks of treatment with the drug, which is under development by Germany-based Boehringer ...

Nutritional sports supplements sold in Australia test positive for banned androgens

2014-06-23
CHICAGO, IL — Some nutritional sports supplements marketed to athletes -- claiming to help them build lean muscle, reduce body fat and enhance endurance -- are secretly fortified with androgens, which are banned from use in sports, a new study from Australia finds. The results will be presented in a poster Sunday, June 22, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago. "The point is that 'you can't judge a book by its cover.' The nutritional supplement label may not disclose all ingredients, and ...

University scientists unraveling nature of Higgs boson

2014-06-23
MANHATTAN, Kansas — New physics research involving Kansas State University faculty members has helped shed light on how our universe works. A recently published study in the journal Nature Physics reports scientists have found evidence that the Higgs boson — a fundamental particle proposed in 1964 and discovered in 2012 — is the long sought-after particle responsible for giving mass to elementary particles. "In nature, there are two types of particles: fermions and bosons," said Ketino "Keti" Kaadze, a research associate at Fermilab who in August is joining the faculty ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] Low number of taste buds linked to older age, higher fasting blood sugar